白虎汤治疗脓毒症的临床观察

被引:21
作者
胡星星
刘绛云
郭静生
俞辰斌
倪海滨
机构
[1] 南京中医药大学附属中西医结合医院
关键词
白虎汤; 地塞米松; 脓毒症; 热毒内盛证; 细胞因子;
D O I
暂无
中图分类号
R278 [中医急症学];
学科分类号
100502 [中医临床基础];
摘要
目的观察白虎汤治疗脓毒症的临床疗效。方法将60例脓毒症患者按随机数字表法分为白虎汤组和激素组各30例,两组均予西医常规治疗,白虎汤组予白虎汤汤剂治疗,激素组予地塞米松治疗,观察两组患者的临床疗效。结果两组治疗后白细胞细素-6(IL-6)、白细胞介素-10(IL-10)、单核细胞人白细胞DR抗原(HLA-DR)、白细胞(WBC)、C反应蛋白(CRP)均有改善,白虎汤组改善程度优于激素组(P<0.05)。两组治疗前后SOFA评分组内差异有统计学意义(P<0.05),组间差异无统计学意义(P>0.05)。结论白虎汤治疗脓毒症(毒热内盛证)患者,在减轻炎症反应、调节免疫功能、保护器官功能方面优于优于地塞米松,且无激素不良反应。
引用
收藏
页码:2192 / 2194
页数:3
相关论文
共 9 条
[1]
白虎汤对脓毒症患者的免疫调理作用 [J].
胡星星 ;
刘绛云 ;
刘克琴 ;
俞辰斌 ;
倪海滨 .
中国中医急症, 2016, 25 (02) :251-253+258
[2]
Using inflammatory and oxidative biomarkers in urine to predict early acute kidney injury in patients undergoing liver transplantation.[J].Dezhao Liu;Pinjie Huang;Xiaoyun Li;Mian Ge;Gangjian Luo;Ziqing Hei.Biomarkers.2014, 5
[3]
Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia [J].
Remmelts, Hilde H. F. ;
Meijvis, Sabine C. A. ;
Heijligenberg, Rik ;
Rijkers, Ger T. ;
Oosterheert, Jan Jelrik ;
Bos, Willem Jan W. ;
Endeman, Henrik ;
Grutters, Jan C. ;
Hoepelman, Andy I. M. ;
Biesma, Douwe H. .
JOURNAL OF INFECTION, 2012, 65 (01) :25-31
[4]
Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury [J].
Liu, Kathleen D. ;
Glidden, David V. ;
Eisner, Mark D. ;
Parsons, Polly E. ;
Ware, Lorraine B. ;
Wheeler, Arthur ;
Korpak, Anna ;
Thompson, Taylor ;
Chertow, Glenn M. ;
Matthay, Michael A. .
CRITICAL CARE MEDICINE, 2007, 35 (12) :2755-2761
[5]
Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis [J].
Pettilä, V ;
Hynninen, M ;
Takkunen, I ;
Kuusela, P ;
Valtonen, M .
INTENSIVE CARE MEDICINE, 2002, 28 (09) :1220-1225
[6]
Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study [J].
Briegel, J ;
Forst, H ;
Haller, M ;
Schelling, G ;
Kilger, E ;
Kuprat, G ;
Hemmer, B ;
Hummel, T ;
Lenhart, A ;
Heyduck, M ;
Stoll, C ;
Peter, K .
CRITICAL CARE MEDICINE, 1999, 27 (04) :723-732
[7]
Sepsis and serum cytokine concentrations [J].
Damas, P ;
Canivet, JL ;
DeGroote, D ;
Vrindts, Y ;
Albert, A ;
Franchimont, P ;
Lamy, M .
CRITICAL CARE MEDICINE, 1997, 25 (03) :405-412
[8]
CORTICOSTEROID TREATMENT FOR SEPSIS - A CRITICAL-APPRAISAL AND METAANALYSIS OF THE LITERATURE [J].
CRONIN, L ;
COOK, DJ ;
CARLET, J ;
HEYLAND, DK ;
KING, D ;
LANSANG, MAD ;
FISHER, CJ .
CRITICAL CARE MEDICINE, 1995, 23 (08) :1430-1439
[9]
STEROID CONTROVERSY IN SEPSIS AND SEPTIC SHOCK - A METAANALYSIS [J].
LEFERING, R ;
NEUGEBAUER, EAM .
CRITICAL CARE MEDICINE, 1995, 23 (07) :1294-1303